This BCC Research report is an analysis of the Raman spectroscopy market which includes factors currently driving and restraining the growth of the market, as well as factors impacting the future of the industry. Forecasts provided from 2016 through 2021.
This BCC Research report forecasts the embedded technology market through 2021 by considering macroeconomic factors and dynamics of the markets for various end products. It also provides measurement and analysis of major market segments and highlights major players and emerging trends affecting the market.
This BCC Research report highlights the main segments of the glycobiology industry and its major market participants, including current and future market trends. Forecast provided from 2016 through 2021.
This BCC Research report studies the global and regional markets for various specialty chemicals used in water treatment processes, with the purpose of discovering newer markets and understanding the current market for these chemicals. Forecasts provided through 2021.
This BCC Research report identifies areas of growth within the cardiovascular surgical device market and discusses innovative technologies that have been recently launched or are presently under development. Forecasts provided through 2020.
This BCC Research report explores present and future strategies within the food processing and packaging equipment market, and detailed analysis of the market for food processing and packaging equipment. Includes forecast through 2020.
Sharply Rising Prevalence of Diabetes Driving Growth in Global Markets
The worldwide prevalence of type 2 diabetes is reaching epidemic proportions. According to the International Diabetes Federation and other professional bodies, the global population of adults with diabetes (types 1 and 2) was approximately 415 million in 2015; that number is expected to rise to 642 million people by 2040. This trend is of grave concern to patients, healthcare providers, and governments. In addition to the direct burden of managing the disease, common and often catastrophic complications include cardiovascular disease, peripheral neuropathy, and blindness. Prompt diagnosis and effective treatment of diabetes are essential priorities for healthcare agencies and governments. The economic consequences of diabetes are also vast.
2-D Nanomaterial Outperforms Graphene in EMI Shielding
Since the beginning of the universe, electromagnetic radiation has been with us. But in recent decades, both the progression of technology and proliferation of electronics have contributed to a dramatic increase in electromagnetic interference (EMI).
Pharma Thinks Beyond the Pill: Connected Devices are a Smart Strategy
MedCrypt, a medical device software security company, just announced the closing of $750,000 in seed round financing. With patient data increasingly at risk, the FDA has called for device manufacturers to strengthen their software security. This mandate creates big opportunities for companies like MedCrypt, which works with manufacturers to prevent unauthorized access and use of their medical devices. The worst-case scenario was illustrated in MedCrypt’s press release.
App Senses Flat Suds
Flat beer is the scourge of beer drinkers, homebrewers, craft brewers and beer corporations alike. No one likes a flat-tasting beer.
New Thinner, Flatter Lens May Revolutionize Optics
Researchers have invented a flat lens composed of paint whitener on a sliver of glass that may revolutionize optics. They claim the ultra-thin flat—or planar—lens works efficiently within the visible spectrum of light, covering the entire range of colors from red to blue.
The discovery should lead the way to lighter, less-bulky cameras, telescopes, and cell phones, say the researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).
Mylan’s EpiPen is Just the Latest Contributor to Drug-Pricing Debate
There’s a constant grumbling in the background when it comes to the prices of pharmaceuticals. Treatments for oncology and the hepatitis C virus are widely cited as among the most expensive medications. So, too, are certain therapies for orphan indications. The latest example to evoke widespread criticism is that of Mylan NV’s EpiPen device for treatment of severe allergic reactions. The EpiPen’s price has soared more than 400% since Mylan acquired the product in 2007, to more than $600 now, sparking outrage from patients, consumers, and politicians.
Do Orphan Drugs Significantly Contribute to Healthcare Spending?
A new analysis finds that growing concerns about spending on prescription drugs that treat rare diseases are not justified. Researchers at IMS Health and Celgene Corporation analyzed US pharmaceutical spending from 2007 to 2013 on more than 300 drugs that had orphan approval under the 1983 Orphan Drug Act, which has long been considered a success for encouraging the production of hundreds of drugs for rare diseases.
Swedish Study Calls Out Software Flaws in fMRI Results
Software packages that analyze the results of functional magnetic resonance imaging (fMRI) contain flaws that showed false brain activity on 60 percent of images, claim Swedish researchers. A reasonable percentage is five.